Mitral Valve Insufficiency Clinical Trial
Official title:
The Effect of Posterior Annulus Elevation Technique in Reducing Residual Regurgitation During Mitral Valve Repair in Children
The main problem in mitral valve repair surgery in children is the high number of postoperative residual lesions (49% of the total cases). Residual lesions after mitral valve repair are associated with morbidity and complications in the form of hemolysis and could affect the postoperative reverse remodeling process. Surgery techniques for mitral valve repair in children have fewer choices than adult patients because of the smaller and thinner valve structure. Besides, the weakness of the mitral valve repair technique that often occurs in large left ventricles with severe mitral regurgitation, after repairing with ring annuloplasty, there is usually a mild residual regurgitation due to posterior mitral leaflet that tends to become restrictive due to being attracted by the left ventricular wall that remains big. No technique has been found to overcome the problem of mitral regurgitation residuals that occur postoperatively. Therefore, by analyzing postoperative mitral valve structural abnormalities with conventional techniques, an additional posterior mitral valve elevation technique was designed to increase the area of coaptation between two leaves of the mitral valve so that the incidence of postoperative regurgitation lesions can be reduced.
Status | Not yet recruiting |
Enrollment | 58 |
Est. completion date | August 17, 2022 |
Est. primary completion date | August 17, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Month to 18 Years |
Eligibility |
Inclusion Criteria: 1. Patients with mitral regurgitation heart disease. 2. Patients with an age range of 1 day - 18 years 3. Patients with mitral regurgitation heart disease with atrial septal defects 4. Mitral valve repair surgery performed by single surgeon (Budi Rahmat, MD) Exclusion Criteria: 1. Patients refuse to participate in the study. 2. Having additional cardiac abnormalities other than atrial septal defects that change the surgery plan. 3. Reoperation mitral valve surgery. 4. History of abnormalities in the central nervous system / preoperative stroke. 5. Patients with severe pulmonary hypertension 6. Patients with small left ventricles (LV smallish) 7. History of pulmonary resuscitation (CPR) before surgery. Dropout Criteria 1. The patient fails to complete the entire examination procedure. 2. Mitral regurgitation patients who are decided to do mitral valve replacement intra-operatively. 3. Using extracorporeal life support (ECMO) device after surgery. 4. History of intra-operative CPR. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
National Cardiovascular Center Harapan Kita Hospital Indonesia |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Residual mitral valve regurgitation | Residual mitral valve regurgitation is measured using transesophageal echocardiography and transthoracic echocardiography | 5 days after surgery | |
Primary | Mitral valve coaptation area | Mitral valve coaptation area is measured using transesophageal echocardiography and transthoracic echocardiography | Intraoperative | |
Primary | Change of Haptoglobin at 3 months after surgery | Serum haptoglobin level that indicated the presence of intravascular hemolysis is measured after the surgery | Preoperative (baseline), 5 days, 2 weeks and 3 months after surgery | |
Primary | Change of Lactate dehydrogenase at 3 months after surgery | Lactate dehydrogenase level that indicated the presence of intravascular hemolysis is measured after the surgery | Preoperative (baseline), 5 days, 2 weeks and 3 months after surgery | |
Primary | Change of NT-proBNP at 3 months after surgery | NTproBNP is a marker of acute heart failure and indicates the process of heart remodeling. | Preoperative (baseline), 5 days, 2 weeks and 3 months after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03962023 -
Prognostic Impact of Imaging Parameters in Patients With Primary Mitral Insufficiency by Prolapse (COHORTE-IM)
|
||
Withdrawn |
NCT02624960 -
Safety and Performance of the AccuCinch® System
|
N/A | |
Terminated |
NCT02428010 -
Twelve Transcatheter Mitral Valve Replacement (TMVR) Pilot Study
|
N/A | |
Active, not recruiting |
NCT01533883 -
Cardioband Adjustable Annuloplasty System for Minimally Invasive Mitral Valve Repair
|
N/A | |
Unknown status |
NCT01201070 -
Study of Administration Of Antithrombin in Patients With Low Plasmatic Levels of Antithrombin After Cardiac Surgery
|
Phase 4 | |
Terminated |
NCT00700947 -
Using Beta Blockers to Treat Mitral Regurgitation
|
Phase 1 | |
Completed |
NCT04351984 -
Transcatheter Mitral Valvuloplasty Pilot Study
|
||
Completed |
NCT04231331 -
Ertugliflozin for Functional Mitral Regurgitation
|
Phase 3 | |
Completed |
NCT05742789 -
Effect of Anesthetics on Troponin I and ะก-reactive Protein
|
Phase 1 | |
Recruiting |
NCT02803957 -
Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair
|
N/A | |
Recruiting |
NCT04153292 -
The ENCIRCLE Trial
|
N/A | |
Completed |
NCT02607527 -
Annular Reshaping of the Mitral Valve for Patients With Mitral Regurgitation Using the Millipede IRIS System
|
N/A | |
Active, not recruiting |
NCT03066050 -
Long Term Follow Up for CTSN Mitral Valve Repair Studies
|
||
Active, not recruiting |
NCT04443218 -
Edwards PASCAL Transcatheter Valve Repair System Registry
|
||
Enrolling by invitation |
NCT04067635 -
Primary Mitral Regurgitation Repair
|
||
Completed |
NCT01966146 -
Examination of Valve Insufficiency Before and After MitraClip or TAVI Procedure by 3D Echocardiography Compared to MRI
|
N/A | |
Recruiting |
NCT01368575 -
Surgical Treatment of Ischemic Mitral Regurgitation
|
Phase 4 | |
Completed |
NCT00001314 -
Investigation of Heart Function in Patients With Heart Valve Defects
|
N/A | |
Terminated |
NCT03285724 -
Safety and Performance Study of the Harpoon Mitral Valve Repair System
|
N/A | |
Withdrawn |
NCT04709042 -
Acquisition of Objective Data During Transapical Neochordae Implantation
|
N/A |